{
 "as_of": "2026-11-06",
 "cmr": "se-cm-kg/XSTO/SE0012675361",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# IRLAB Therapeutics AB ser. A (Nasdaq Stockholm: SE0012675361) — research page\n\nAs of 2026-11-06 · se-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is IRLAB Therapeutics AB ser. A, listed on Nasdaq Stockholm under ticker SE0012675361, with ISIN SE0012675361 and LEI 549300JAT34LHEI0DH60. Its security type, segment, sector and jurisdiction are not on the record. Its status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 40 filings across 37 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 7.5 days. The latest filing is dated 2026-11-06 and is of type Investor News, 0 days before the record date of 2026-11-06. Nasdaq Stockholm has 398 issuers with a median of 30.0 filings, a median cadence gap of 9.5 days and a median latency of 7.0 days. The sector median is not on the record.\n\n## Auditor\n\nThe auditor and its location are not on the record. Auditor changes are not on the record, as this register has no lifecycle type map yet.\n\n## Events and halts\n\nListing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The halt flag shows the issuer as listed, not halted.\n\n## Orderability\n\nThe outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/se/mifid-ii-product-governance/r1, with the chapter as of 2026-11-04.\n\n## Coverage\n\nThe record holds one research house named on the issuer's investor-relations page, Redeye.\n\n## Open research\n\nNo openly published research notes were found on the record.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe market's vintage is not sealed. No issuer years are sealed, and the earliest sealed date of the market and the date the live record began are not on the record.\n\n## Sources\n\n7 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://firds.esma.europa.eu/firds/ (identity.exchange)\n- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)\n- https://mcp.se-cm-kg.ai/events/XSTO/SE0012675361 (the disclosure lines)\n- https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation (the halt flag)\n- https://se.eu-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://irlab.se/investor-relations/ (coverage)\n- https://mcp.se-cm-kg.ai/record/XSTO/SE0012675361 (the record)\n",
 "market": "SE",
 "node": "se-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": null,
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "the SE vintage is not sealed; the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false
  },
  "auditor": {
   "auditor": {
    "market": "SE",
    "state": "not_on_record"
   },
   "auditor_firm_id": {
    "market": "SE",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "SE",
    "state": "not_on_record"
   },
   "changes": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "cmr": "se-cm-kg/XSTO/SE0012675361",
  "coverage": {
   "count": 1,
   "houses": [
    {
     "house": "Redeye",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://irlab.se/investor-relations/",
     "state": "sourced"
    }
   ],
   "pages_checked": [
    {
     "page": "https://irlab.se/investor-relations/",
     "result": "read: 1 of 3 named houses found on the page"
    }
   ],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": "not stated on the page read",
   "state": "found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 398,
     "median_cadence_gap_days": 9.5,
     "median_filings": 30,
     "median_latency_days": 7,
     "name": "Nasdaq Stockholm"
    },
    "sector": {
     "market": "SE",
     "state": "not_on_record"
    }
   },
   "by_type": {
    "Annual Financial Report": 1,
    "Decisions of general meeting": 2,
    "Financial Statement Release": 1,
    "Half Year financial report": 1,
    "Inside information": 4,
    "Interim report (Q1 and Q3)": 1,
    "Investor News": 20,
    "Notice to general meeting": 2,
    "Other information disclosed according to the rules of the Exchange": 5,
    "Prospectus/Announcement of Prospectus": 1,
    "Total number of voting rights and capital": 2
   },
   "cadence_median_gap_days": 7.5,
   "filing_days": 37,
   "filings": 40,
   "latency_days": 0,
   "latest": [
    {
     "category": "Investor News",
     "date": "2026-11-06",
     "source": "https://view.news.eu.nasdaq.com/view?id=bf51e85460aea8d2199981f6231e80f5b&lang=en&src=listed",
     "title": "IRLAB: Invitation to the interim report for Q3 2026 presentation and webcast",
     "type": "Investor News"
    },
    {
     "category": "Investor News",
     "date": "2026-10-27",
     "source": "https://view.news.eu.nasdaq.com/view?id=b7add5428fd8bbdcd752c56801c34c379&lang=en&src=listed",
     "title": "The U.S. Patent and Trademark Office has issued a Notice of Allowance for a patent covering IRLAB's drug candidate IRL1117",
     "type": "Investor News"
    },
    {
     "category": "Other information disclosed according to the rules of the Exchange",
     "date": "2026-10-20",
     "source": "https://view.news.eu.nasdaq.com/view?id=b53fae96783302fc51226478962d0c112&lang=en&src=listed",
     "title": "Nomination committee appointed for IRLAB's annual general meeting 2027",
     "type": "Other information disclosed according to the rules of the Exchange"
    },
    {
     "category": "Investor News",
     "date": "2026-10-20",
     "source": "https://view.news.eu.nasdaq.com/view?id=b055ccd7eb7704601b00d94dbddd498c1&lang=en&src=listed",
     "title": "IRLAB's Preclinical Research Underpinning Linepemat Published in Peer-Reviewed Journal",
     "type": "Investor News"
    },
    {
     "category": "Investor News",
     "date": "2026-10-09",
     "source": "https://view.news.eu.nasdaq.com/view?id=b6fec87d9f910a4d83c280fbe4984baf6&lang=en&src=listed",
     "title": "IRLAB to present at Redeye Theme: Neurology",
     "type": "Investor News"
    }
   ],
   "latest_filing_date": "2026-11-06",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.se-cm-kg.ai/events/XSTO/SE0012675361",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "Nasdaq Stockholm"
   },
   "isin": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "SE0012675361"
   },
   "jurisdiction": {
    "market": "SE",
    "state": "not_on_record"
   },
   "lei": {
    "read_by": "GLEIF ISIN-to-LEI mapping file (daily), LEI by exact ISIN",
    "read_date": "2026-11-09",
    "read_date_basis": "the field",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download (ISIN SE0012675361)",
    "state": "sourced",
    "value": "549300JAT34LHEI0DH60"
   },
   "name": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "IRLAB Therapeutics AB ser. A"
   },
   "sector": {
    "market": "SE",
    "state": "not_on_record"
   },
   "security_type": {
    "market": "SE",
    "state": "not_on_record"
   },
   "segment": {
    "market": "SE",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "SE0012675361"
   },
   "website": {
    "market": "SE",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "domicile_change": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "listing": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "name_change": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "segment_move": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "market": "SE",
  "node": "se-cm-kg",
  "numbers_hash": "sha256:7bc5f8e98c84816453cf3b6809815d5d6d018a90356615f12d783db1ac7b0843",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://se.eu-cm-kg.ai/book/aio.json",
    "door": "https://se.eu-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/se/mifid-ii-product-governance/r1",
   "section": "se.aio.v5"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.se-cm-kg.ai/record/XSTO/SE0012675361",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-09",
   "source": "https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:7bc5f8e98c84816453cf3b6809815d5d6d018a90356615f12d783db1ac7b0843",
 "path": "/se/XSTO/SE0012675361",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is IRLAB Therapeutics AB ser. A, listed on Nasdaq Stockholm under ticker SE0012675361, with ISIN SE0012675361 and LEI 549300JAT34LHEI0DH60. Its security type, segment, sector and jurisdiction are not on the record. Its status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 40 filings across 37 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 7.5 days. The latest filing is dated 2026-11-06 and is of type Investor News, 0 days before the record date of 2026-11-06. Nasdaq Stockholm has 398 issuers with a median of 30.0 filings, a median cadence gap of 9.5 days and a median latency of 7.0 days. The sector median is not on the record.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor and its location are not on the record. Auditor changes are not on the record, as this register has no lifecycle type map yet.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "Listing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The halt flag shows the issuer as listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/se/mifid-ii-product-governance/r1, with the chapter as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "The record holds one research house named on the issuer's investor-relations page, Redeye.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found on the record.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The market's vintage is not sealed. No issuer years are sealed, and the earliest sealed date of the market and the date the live record began are not on the record.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "7 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://firds.esma.europa.eu/firds/"
  },
  {
   "for": "identity.lei",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.se-cm-kg.ai/events/XSTO/SE0012675361"
  },
  {
   "for": "the halt flag",
   "source": "https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation"
  },
  {
   "for": "the orderability chapter",
   "source": "https://se.eu-cm-kg.ai/book/aio.json"
  },
  {
   "for": "coverage",
   "source": "https://irlab.se/investor-relations/"
  },
  {
   "for": "the record",
   "source": "https://mcp.se-cm-kg.ai/record/XSTO/SE0012675361"
  }
 ],
 "title": "IRLAB Therapeutics AB ser. A (SE0012675361) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}